Literature DB >> 19266397

Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.

Janine R Danko1, William R Gilliland, R Scott Miller, Catherine F Decker.   

Abstract

Tumor necrosis factor-alpha inhibitors are important adjunctive therapies for rheumatologic diseases. These agents increase the risk for granulomatous disease. We present a case of a woman with severe rheumatoid arthritis on infliximab who developed multiple nodular skin lesions. Biopsies grew Mycobacterium marinum. New lesions developed through therapy, necessitating surgical debulking.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19266397     DOI: 10.1080/00365540902774599

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  8 in total

1.  Soft tissue infections caused by marine bacterial pathogens: epidemiology, diagnosis, and management.

Authors:  Renato Finkelstein; Ilana Oren
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 2.  Is continuation of anti-tumor necrosis factor-α therapy a safe option for patients who have developed pulmonary mycobacterial infection? : Case presentation and literature review.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Clin Rheumatol       Date:  2011-12-15       Impact factor: 2.980

3.  Mycobacterium marinum: an increasingly common opportunistic infection in patients on infliximab.

Authors:  Jason Ferreira; Jared Grochowsky; Douglas Krakower; Peter Zuromskis; Rachel Baden; Adam S Cheifetz
Journal:  Am J Gastroenterol       Date:  2012-08       Impact factor: 10.864

4.  Radiological features and therapeutic responses of pulmonary nontuberculous mycobacterial disease in rheumatoid arthritis patients receiving biological agents: a retrospective multicenter study in Japan.

Authors:  Shunsuke Mori; Hitoshi Tokuda; Fumikazu Sakai; Takeshi Johkoh; Akio Mimori; Norihiro Nishimoto; Sadatomo Tasaka; Kazuhiro Hatta; Hidekazu Matsushima; Shunji Kaise; Atsushi Kaneko; Shigeki Makino; Seiji Minota; Takashi Yamada; Shinobu Akagawa; Atsuyuki Kurashima
Journal:  Mod Rheumatol       Date:  2011-12-30       Impact factor: 3.023

5.  Cellular immune responses in HIV-negative immunodeficiency with anti-interferon-γ antibodies and opportunistic intracellular microorganisms.

Authors:  Jiraprapa Wipasa; Panuwat Wongkulab; Kriangkrai Chawansuntati; Romanee Chaiwarit; Khuanchai Supparatpinyo
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

6.  First Reported Mycobacterium Marinum Infection Case in a Patient With Psoriatic Arthritis Maintained on Golimumab.

Authors:  Mohamad Ali Rida; Tara Bardawil; Dima Ibrahim
Journal:  Arch Rheumatol       Date:  2020-02-07       Impact factor: 1.472

7.  Disseminated Invasive Mycobacterium marinum Infection Involving the Lung of a Patient with Diabetes Mellitus.

Authors:  Tae Hoon Oh; Uh Jin Kim; Seung Ji Kang; Hee Chang Jang; Kyung Hwa Park; Sook In Jung; Joon Hwan Ahn
Journal:  Infect Chemother       Date:  2018-03

8.  Flare or foe? - Mycobacterium marinum infection mimicking rheumatoid arthritis tenosynovitis: case report and literature review.

Authors:  Nils Schubert; Tillmann Schill; Marlene Plüß; Peter Korsten
Journal:  BMC Rheumatol       Date:  2020-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.